Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Osteoporosis

  Free Subscription


Articles published in J Clin Endocrinol Metab

Retrieve available abstracts of 86 articles:
HTML format
Text format



Single Articles


    March 2017
  1. WANG Y, Wactawski-Wende J, Sucheston-Campbell LE, Preus L, et al
    Gene-hormone therapy interaction and fracture risk in postmenopausal women.
    J Clin Endocrinol Metab. 2017 Mar 6. doi: 10.1210/jc.2016-2936.
    PubMed     Text format     Abstract available


    February 2017
  2. NOTSU M, Yamauchi M, Yamamoto M, Nawata K, et al
    Primary aldosteronism as a risk factor for vertebral fracture.
    J Clin Endocrinol Metab. 2017 Feb 9. doi: 10.1210/jc.2016-3206.
    PubMed     Text format    


    January 2017
  3. VUORIMIES I, Mayranpaa MK, Valta H, Kroger H, et al
    Bisphosphonate Treatment and the Characteristics of Femoral Fractures in Children with Osteogenesis Imperfecta.
    J Clin Endocrinol Metab. 2017 Jan 17. doi: 10.1210/jc.2016-3745.
    PubMed     Text format     Abstract available


    November 2016
  4. OHLSSON C, Sundh D, Wallerek A, Nilsson M, et al
    Cortical bone area predicts incident fractures independently of areal bone mineral density in older men.
    J Clin Endocrinol Metab. 2016 Nov 22:jc20163177.
    PubMed     Text format     Abstract available


  5. CHAWLA H, Saha S, Kandaswamy D, Sharma R, et al
    Vertebral fractures and bone mineral density in patients with idiopathic hypoparathyroidism on long term follow-up.
    J Clin Endocrinol Metab. 2016 Nov 4:jc20163292.
    PubMed     Text format     Abstract available


    October 2016
  6. VALIMAKI VV, Makitie O, Pereira R, Laine C, et al
    Teriparatide Treatment in Patients with WNT1 or PLS3 Mutation-Related Early-Onset Osteoporosis - A Pilot Study.
    J Clin Endocrinol Metab. 2016 Oct 12:jc20162423.
    PubMed     Text format     Abstract available


  7. LAMY O, Gonzalez-Rodriguez E, Stoll D, Hans D, et al
    Severe rebound-associated vertebral fractures after denosumab discontinuation: nine clinical cases report.
    J Clin Endocrinol Metab. 2016 Oct 12:jc20163170.
    PubMed     Text format     Abstract available


    September 2016
  8. ESCHE J, Johner S, Shi L, Schonau E, et al
    Urinary citrate, an index of acid-base status, predicts bone strength in youths and fracture risk in adult females.
    J Clin Endocrinol Metab. 2016 Sep 27:jc20162677.
    PubMed     Text format     Abstract available


  9. MAJUMDAR SR, Leslie WD, Lix LM, Morin SN, et al
    Longer Duration of Diabetes Strongly Impacts Fracture Risk Assessment: The Manitoba BMD Cohort.
    J Clin Endocrinol Metab. 2016 Sep 7:jc20162569.
    PubMed     Text format     Abstract available


  10. MILLER PD, Pannacciulli N, Wagman RB, Cummings SR, et al
    Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.
    J Clin Endocrinol Metab. 2016;101:L91-2.
    PubMed     Text format    


  11. MAKRAS P, Polyzos SA, Anastasilakis AD
    Letter to the Editor: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid.
    J Clin Endocrinol Metab. 2016;101:L89-90.
    PubMed     Text format    


    August 2016
  12. KOCIJAN R, Muschitz C, Geiger E, Skalicky S, et al
    Circulating microRNA signatures in patients with idiopathic and postmenopausal osteoporosis and fragility fractures.
    J Clin Endocrinol Metab. 2016 Aug 23:jc20162365.
    PubMed     Text format     Abstract available


  13. WAGENKNECHT LE, Divers J, Register TC, Russell GB, et al
    Bone mineral density and progression of subclinical atherosclerosis in African Americans with type 2 diabetes.
    J Clin Endocrinol Metab. 2016 Aug 23:jc20161934.
    PubMed     Text format     Abstract available


  14. SUGIYAMA T, Oda H
    Letter to the Editor: Combination Treatment With Teriparatide and Denosumab in Osteoporosis.
    J Clin Endocrinol Metab. 2016;101:L80-1.
    PubMed     Text format    


    June 2016
  15. CARTWRIGHT B, Robinson J, Seed PT, Fogelman I, et al
    Hormone replacement therapy versus the combined oral contraceptive pill in premature ovarian failure: a randomised controlled trial of the effects on bone mineral density.
    J Clin Endocrinol Metab. 2016 Jun 24:jc20154063.
    PubMed     Text format     Abstract available


  16. CHANG PY, Gold EB, Cauley JA, Johnson WO, et al
    Triglyceride Levels and Fracture Risk in Midlife Women: Study of Women's Health Across the Nation (SWAN).
    J Clin Endocrinol Metab. 2016 Jun 13:jc20161366.
    PubMed     Text format     Abstract available


  17. MILLER PD, Pannacciulli N, Brown JP, Czerwinski E, et al
    Denosumab or Zoledronic Acid in Postmenopausal Women With Osteoporosis Previously Treated With Oral Bisphosphonates.
    J Clin Endocrinol Metab. 2016 Jun 6:jc20161801.
    PubMed     Text format     Abstract available


    May 2016
  18. AFSHINNIA F, Pennathur S
    Association of Hypoalbuminemia with Osteoporosis: Analysis of the National Health and Nutrition Examination Survey.
    J Clin Endocrinol Metab. 2016 May 4:jc20161099.
    PubMed     Text format     Abstract available


  19. MORELLI V, Eller-Vainicher C, Palmieri S, Cairoli E, et al
    Prediction of vertebral fractures in patients with monolateral adrenal incidentalomas.
    J Clin Endocrinol Metab. 2016 May 4:jc20161423.
    PubMed     Text format     Abstract available


  20. SUGIYAMA T, Kim YT, Oda H
    Letter to the Editor: Strontium Ranelate in the Treatment of Osteoporosis: A Possible Mechanism.
    J Clin Endocrinol Metab. 2016;101:L64-5.
    PubMed     Text format    


  21. AMREIN K, Perl S, Dimai HP
    Letter to the Editor: Preadmission Bisphosphonate and Mortality in Critically Ill Patients.
    J Clin Endocrinol Metab. 2016;101:L60-1.
    PubMed     Text format    


    March 2016
  22. MAJUMDAR SR, Josse RG, Lin M, Eurich DT, et al
    Does Sitagliptin Affect the Rate of Osteoporotic Fractures in Type-2 Diabetes? Population-Based Cohort Study.
    J Clin Endocrinol Metab. 2016 Mar 1:jc20154180.
    PubMed     Text format     Abstract available


  23. MILLER PD
    Underdiagnoses and Undertreatment of Osteoporosis: The Battle to Be Won.
    J Clin Endocrinol Metab. 2016;101:852-859.
    PubMed     Text format     Abstract available


  24. KRONENBERG HM
    Bone and Mineral Metabolism: Where Are We, Where Are We Going, and How Will We Get There?
    J Clin Endocrinol Metab. 2016;101:795-8.
    PubMed     Text format     Abstract available


    February 2016
  25. UPALA S, Sanguankeo A
    Association Between Hyponatremia, Osteoporosis and Fracture: a Systematic Review and Meta-analysis.
    J Clin Endocrinol Metab. 2016 Feb 25:jc20154228.
    PubMed     Text format     Abstract available


  26. CARBONE L, Johnson KC, Huang Y, Pettinger M, et al
    Sodium Intake and Osteoporosis. Findings from the Women's Health Initiative.
    J Clin Endocrinol Metab. 2016 Feb 10:jc20154017.
    PubMed     Text format     Abstract available


  27. DEMPSTER DW, Zhou H, Recker RR, Brown JP, et al
    Differential Effects of Teriparatide and Denosumab on Intact PTH and Bone Formation Indices: AVA Osteoporosis Study.
    J Clin Endocrinol Metab. 2016 Feb 9:jc20154181.
    PubMed     Text format     Abstract available


    January 2016
  28. LEE P, Ng C, Slattery A, Nair P, et al
    Preadmission bisphosphonate and mortality in critically ill patients.
    J Clin Endocrinol Metab. 2016 Jan 18:jc20153467.
    PubMed     Text format     Abstract available


  29. LEE SH, Cho EH, Ahn SH, Kim HM, et al
    Prediction of Future Osteoporotic Fracture Occurrence by Genetic Profiling: A 6-year Follow-up Observational Study.
    J Clin Endocrinol Metab. 2016 Jan 12:jc20153972.
    PubMed     Text format     Abstract available


  30. TABATABAI LS, Bloom J, Stewart S, Sellmeyer DE, et al
    FSH Levels Predict Bone Loss in Premenopausal Women Treated for Breast Cancer More Than One Year After Treatment.
    J Clin Endocrinol Metab. 2016 Jan 12:jc20153149.
    PubMed     Text format     Abstract available


  31. MARTIN BR, McCabe GP, McCabe L, Jackson GS, et al
    Effect of Hesperidin with and without a Calcium (Calcilock(R)) Supplement on Bone Health in Postmenopausal Women.
    J Clin Endocrinol Metab. 2016 Jan 11:jc20153767.
    PubMed     Text format     Abstract available


  32. WALKER MD, Nishiyama KK, Zhou B, Cong E, et al
    Effect of Low Vitamin D on Volumetric Bone Mineral Density, Bone Microarchitecture and Stiffness in Primary Hyperparathyroidism.
    J Clin Endocrinol Metab. 2016 Jan 8:jc20154218.
    PubMed     Text format     Abstract available


    December 2015
  33. MUKA T, de Jonge EA, Kiefte-de Jong JC, Uitterlinden AG, et al
    The influence of serum uric acid on bone mineral density, hip geometry and fracture risk: The Rotterdam Study.
    J Clin Endocrinol Metab. 2015 Dec 18:jc20152446.
    PubMed     Text format     Abstract available


  34. KIZILGUL M, Sencar E, Ucan B, Ozbek M, et al
    Letter to the Editor: Possible Decrease in GIP Levels May Explain Increased Plasma Dipeptidyl Peptidase-4 Activity-Associated Osteoporosis.
    J Clin Endocrinol Metab. 2015;100:L128-9.
    PubMed     Text format    


    November 2015
  35. AFSHINNIA F, Wong KK, Sundaram B, Ackermann RJ, et al
    Hypoalbuminemia and Osteoporosis: Reappraisal of a Controversy.
    J Clin Endocrinol Metab. 2015 Nov 24:jc20153212.
    PubMed     Text format     Abstract available


  36. WATTS NB, Bilezikian JP, Usiskin K, Edwards R, et al
    Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2015 Nov 18:jc20153167.
    PubMed     Text format     Abstract available


  37. BILEZIKIAN JP, Watts NB, Usiskin K, Polidori D, et al
    Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin.
    J Clin Endocrinol Metab. 2015 Nov 18:jc20151860.
    PubMed     Text format     Abstract available


  38. SALVATORI R
    Letter to the Editor: Comment on "Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study" by Kratz E., et al.
    J Clin Endocrinol Metab. 2015;100:L107.
    PubMed     Text format    


  39. KRANTZ E, Trimpou P, Landin-Wilhelmsen K
    Response to the Letter by Salvatori R.
    J Clin Endocrinol Metab. 2015;100:L108.
    PubMed     Text format    


  40. VAN VARSSEVELD NC, Sohl E, Drent ML, Lips P, et al
    Gender-Specific Associations of Serum Insulin-Like Growth Factor-1 With Bone Health and Fractures in Older Persons.
    J Clin Endocrinol Metab. 2015;100:4272-81.
    PubMed     Text format     Abstract available


  41. GEORGE S, Weber DR, Kaplan P, Hummel K, et al
    Short-Term Safety of Zoledronic Acid in Young Patients With Bone Disorders: An Extensive Institutional Experience.
    J Clin Endocrinol Metab. 2015;100:4163-71.
    PubMed     Text format     Abstract available


    October 2015
  42. CHAVASSIEUX P, Portero-Muzy N, Paul Roux J, Garnero P, et al
    Are Biochemical Markers of Bone Turnover Representative of Bone Histomorphometry in 370 Postmenopausal Women?
    J Clin Endocrinol Metab. 2015 Oct 27:jc20152957.
    PubMed     Text format     Abstract available


  43. KIZILGUL M, Ozcelik O, Apaydin M, Ozbek M, et al
    Letter to the Editor: Possible Mechanisms of Hyponatremia-Induced Osteoporosis.
    J Clin Endocrinol Metab. 2015;100:L89-90.
    PubMed     Text format    


  44. CONTE C, Cecere A, Guglielmi G, Napoli N, et al
    Letter to the Editor: "GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women" by Iepsen E.W., et al.
    J Clin Endocrinol Metab. 2015;100:L92-3.
    PubMed     Text format    


  45. VERBALIS J
    Response to the Letter to the Editor.
    J Clin Endocrinol Metab. 2015;100:L91.
    PubMed     Text format    


  46. PACCOU J, Hardouin P, Cotten A, Penel G, et al
    The Role of Bone Marrow Fat in Skeletal Health: Usefulness and Perspectives for Clinicians.
    J Clin Endocrinol Metab. 2015;100:3613-21.
    PubMed     Text format     Abstract available


    September 2015
  47. CRANDALL CJ, Hovey KM, Andrews CA, Cauley JA, et al
    Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings from the Women's Health Initiative Study.
    J Clin Endocrinol Metab. 2015 Sep 14:jc20152568.
    PubMed     Text format     Abstract available


  48. COHEN A, Kamanda-Kosseh M, Recker RR, Lappe JM, et al
    Bone Density after Teriparatide Discontinuation in Premenopausal Idiopathic Osteoporosis.
    J Clin Endocrinol Metab. 2015 Sep 10:jc20152829.
    PubMed     Text format     Abstract available


    August 2015
  49. TAN LJ, Wang ZE, Wu KH, Chen XD, et al
    Bivariate Genome-Wide Association Study Implicates ATP6V1G1 as a Novel Pleiotropic Locus Underlying Osteoporosis and Age at Menarche.
    J Clin Endocrinol Metab. 2015 Aug 27:jc20152095.
    PubMed     Text format     Abstract available


  50. KRANTZ E, Trimpou P, Landin-Wilhelmsen K
    Effect of Growth Hormone Treatment on Fractures and Quality of Life in Postmenopausal Osteoporosis: A 10-Year Follow-Up Study.
    J Clin Endocrinol Metab. 2015 Aug 27:jc20151757.
    PubMed     Text format     Abstract available


  51. ZHENG T, Yang L, Liu Y, Liu H, et al
    Increased plasma dipeptidyl peptidase-4 activities are associated with high prevalence of osteoporosis in postmenopausal women with normal glucose tolerance.
    J Clin Endocrinol Metab. 2015 Aug 10:jc20152233.
    PubMed     Text format     Abstract available


  52. BREITLING LP
    Liver enzymes and bone mineral density in the general population.
    J Clin Endocrinol Metab. 2015 Aug 4:jc20152016.
    PubMed     Text format     Abstract available


    July 2015
  53. CUMMINGS EA, Ma J, Fernandez CV, Halton J, et al
    Incident Vertebral Fractures in Children with Leukemia During the Four Years Following Diagnosis.
    J Clin Endocrinol Metab. 2015 Jul 14:JC20152176.
    PubMed     Text format     Abstract available


  54. ING SW, Orchard TS, Lu B, LaMonte MJ, et al
    TNF Receptors Predict Incident Hip Fracture Risk in the WHI Study and Fatty Acid Intake Does Not Modify this Association.
    J Clin Endocrinol Metab. 2015 Jul 10:JC20151662.
    PubMed     Text format     Abstract available


  55. TSAI JN, Zhu Y, Foley K, Lee H, et al
    Comparative Resistance to Teriparatide-Induced Bone Resorption With Denosumab or Alendronate.
    J Clin Endocrinol Metab. 2015;100:2718-23.
    PubMed     Text format     Abstract available


    June 2015
  56. MIRIAM RACHEL USALA G, Fernandez SJ, Mete M, Cowen L, et al
    Hyponatremia is Associated with Increased Osteoporosis and Bone Fractures in a Large U. S. Health System Population.
    J Clin Endocrinol Metab. 2015 Jun 17:jc20151261.
    PubMed     Text format     Abstract available


  57. IEPSEN EW, Lundgren JR, Hartmann B, Pedersen O, et al
    GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women.
    J Clin Endocrinol Metab. 2015 Jun 4:jc20151176.
    PubMed     Text format     Abstract available


    May 2015
  58. COSMAN F, Nieves JW, Zion M, Garrett P, et al
    Daily or Cyclical Teriparatide Treatment in Women with Osteoporosis on no Prior Therapy and Women on Alendronate.
    J Clin Endocrinol Metab. 2015 May 11:jc20151715.
    PubMed     Text format     Abstract available


  59. CHEN CL, Chen NC, Liang HL, Hsu CY, et al
    Effects of Denosumab and Calcitriol on Severe Secondary Hyperparathyroidism in Dialysis Patients with Low Bone Mass.
    J Clin Endocrinol Metab. 2015 May 8:jc20151259.
    PubMed     Text format     Abstract available


    April 2015
  60. YEH MC, Weng SF, Shen YC, Chou CW, et al
    Increased Risk of Sudden Sensorineural Hearing Loss in Patients With Osteoporosis: A Population-based, Propensity Score-matched, Longitudinal Follow-up Study.
    J Clin Endocrinol Metab. 2015 Apr 16:jc20144316.
    PubMed     Text format     Abstract available


  61. SCHULZE-SPATE U, Turner R, Wang Y, Chao R, et al
    Relationship of Bone Metabolism Biomarkers and Periodontal Disease: The Osteoporotic Fractures in Men (MrOS) Study.
    J Clin Endocrinol Metab. 2015 Apr 9:jc20144180.
    PubMed     Text format     Abstract available


    March 2015
  62. TIROSH A, de Souza RJ, Sacks F, Bray GA, et al
    Sex Differences in the Effects of Weight Loss Diets on Bone Mineral Density and Body Composition: POUNDS LOST Trial.
    J Clin Endocrinol Metab. 2015 Mar 31:jc20151050.
    PubMed     Text format     Abstract available


  63. MALGO F, Hamdy NA, Papapoulos SE, Appelman-Dijkstra NM, et al
    Bone Material Strength as measured by microindentation in vivo is decreased in patients with fragility fractures independently of Bone Mineral Density.
    J Clin Endocrinol Metab. 2015 Mar 13:jc20144346.
    PubMed     Text format     Abstract available


    February 2015
  64. CAULEY JA, Greendale GA, Ruppert K, Lian Y, et al
    Serum 25 Hydroxyvitamin D, Bone Mineral Density and Fracture Risk Across the Menopause.
    J Clin Endocrinol Metab. 2015 Feb 26:jc20144367.
    PubMed     Text format     Abstract available


  65. TOULIS KA, Nirantharakumar K, Ryan R, Marshall T, et al
    Bisphosphonates and glucose homeostasis: a population-based, retrospective cohort study.
    J Clin Endocrinol Metab. 2015 Feb 19:jc20143481.
    PubMed     Text format     Abstract available


  66. BAKKER NE, Kuppens RJ, Siemensma EP, Tummers-de Lind van Wijngaarden RF, et al
    Bone Mineral Density in Children and Adolescents with Prader-Willi syndrome: A longitudinal study during puberty and 9 years of Growth Hormone treatment.
    J Clin Endocrinol Metab. 2015 Feb 10:jc20144347.
    PubMed     Text format     Abstract available


  67. CIPRIANI C, Biamonte F, Costa AG, Zhang C, et al
    Prevalence of kidney stones and vertebral fractures in Primary Hyperparathyroidism using imaging technology.
    J Clin Endocrinol Metab. 2015 Feb 3:jc20143708.
    PubMed     Text format     Abstract available


  68. TABATABAI L, Cummings S, Tylavsky F, Bauer D, et al
    Arterialized Venous Bicarbonate is Associated with Lower Bone Mineral Density and an Increased Rate of Bone Loss in Older Men and Women.
    J Clin Endocrinol Metab. 2015 Feb 2:jc20144166.
    PubMed     Text format     Abstract available


    January 2015
  69. LUNDSTAM K, Heck A, Mollerup C, Godang K, et al
    EFFECTS OF PARATHYROIDECTOMY VERSUS OBSERVATION ON THE DEVELOPMENT OF VERTEBRAL FRACTURES IN MILD PRIMARY HYPERPARATHYROIDISM.
    J Clin Endocrinol Metab. 2015 Jan 30:jc20143441.
    PubMed     Text format     Abstract available


  70. LESLIE WD, Majumdar SR, Morin SN, Lix LM, et al
    Why Does Rate of Bone Density Loss Not Predict Fracture Risk?
    J Clin Endocrinol Metab. 2015 Jan 22:jc20143777.
    PubMed     Text format     Abstract available


  71. LANGDAHL BL, Teglbjaerg CS, Ho PR, Chapurlat R, et al
    A 24-month Study Evaluating the Efficacy and Safety of Denosumab for the Treatment of Men With Low Bone Mineral Density: Results From the ADAMO Trial.
    J Clin Endocrinol Metab. 2015 Jan 21:jc20144079.
    PubMed     Text format     Abstract available


  72. ZHUKOUSKAYA VV, Eller Vainicher C, Gaudio A, Cairoli E, et al
    In postmenopausal female subjects with type 2 diabetes mellitus vertebral fractures are independently associated with cortisol secretion and sensitivity.
    J Clin Endocrinol Metab. 2015 Jan 15:jc20144177.
    PubMed     Text format     Abstract available


    December 2014
  73. PALACIOS S, Agodoa I, Bonnick S, Van den Bergh JP, et al
    Treatment Satisfaction in Postmenopausal Women Suboptimally Adherent to Bisphosphonates Who Transitioned to Denosumab Compared with Risedronate or Ibandronate.
    J Clin Endocrinol Metab. 2014 Dec 16:jc20143594.
    PubMed     Text format     Abstract available


  74. MA J, Siminoski K, Alos N, Halton J, et al
    The Choice of Normative Pediatric Reference Database Changes Spine Bone Mineral Density Z-scores But Not The Relationship of Bone Mineral Density With Prevalent Vertebral Fractures.
    J Clin Endocrinol Metab. 2014 Dec 11:jc20143096.
    PubMed     Text format     Abstract available


    November 2014
  75. BERTOLDO F, Zappini F, Brigo M, Moggio M, et al
    Prevalence of asymptomatic vertebral fractures in late-onset Pompe disease.
    J Clin Endocrinol Metab. 2014 Nov 14:jc20142763.
    PubMed     Text format     Abstract available


  76. LEDER BZ, O'Dea LS, Zanchetta JR, Kumar P, et al
    Effects of Abaloparatide, a Human Parathyroid Hormone-related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis.
    J Clin Endocrinol Metab. 2014 Nov 13:jc20143718.
    PubMed     Text format     Abstract available


  77. BREMBECK P, Lorentzon M, Ohlsson C, Winkvist A, et al
    Changes in cortical volumetric bone mineral density and thickness, and trabecular thickness in lactating women postpartum.
    J Clin Endocrinol Metab. 2014 Nov 11:jc20142825.
    PubMed     Text format     Abstract available


  78. BREITLING LP
    Smoking as an Effect Modifier of the Association of Calcium Intake With Bone Mineral Density.
    J Clin Endocrinol Metab. 2014 Nov 11:jc20142190.
    PubMed     Text format     Abstract available


  79. MAZZIOTTI G, Biagioli E, Maffezzoni F, Spinello M, et al
    BONE TURNOVER, BONE MINERAL DENSITY AND FRACTURE RISK IN ACROMEGALY: A META-ANALYSIS.
    J Clin Endocrinol Metab. 2014 Nov 3:jc20142937.
    PubMed     Text format     Abstract available


  80. SUN LM, Lin MC, Muo CH, Liang JA, et al
    Calcitonin nasal spray and increased cancer risk: a population-based nested case-control study.
    J Clin Endocrinol Metab. 2014;99:4259-64.
    PubMed     Text format     Abstract available


  81. MCNABB B, Vittinghoff E, Eastell R, Schwartz AV, et al
    A model of BMD changes after alendronate discontinuation to guide postalendronate BMD monitoring.
    J Clin Endocrinol Metab. 2014;99:4094-100.
    PubMed     Text format     Abstract available


  82. HE H, Zhang L, Li J, Wang YP, et al
    Integrative analysis of GWASs, human protein interaction, and gene expression identified gene modules associated with BMDs.
    J Clin Endocrinol Metab. 2014;99:E2392-9.
    PubMed     Text format     Abstract available


    September 2014
  83. DIEM SJ, Joffe H, Larson JC, Tsai JN, et al
    Effects of escitalopram on markers of bone turnover: a randomized clinical trial.
    J Clin Endocrinol Metab. 2014;99:E1732-7.
    PubMed     Text format     Abstract available


  84. GAJIC-VELJANOSKI O, Tomlinson G, Srighanthan J, Adachi JD, et al
    Effect of odanacatib on BMD and fractures: estimates from Bayesian univariate and bivariate meta-analyses.
    J Clin Endocrinol Metab. 2014;99:3070-9.
    PubMed     Text format     Abstract available


    August 2014
  85. SUTTER S, Nishiyama KK, Kepley A, Zhou B, et al
    Abnormalities in Cortical Bone, Trabecular Plates, and Stiffness in Postmenopausal Women Treated with Glucocorticoids.
    J Clin Endocrinol Metab. 2014 Aug 15:jc20142177.
    PubMed     Text format     Abstract available


    March 2014
  86. BAJAJ A, Stone KL, Peters K, Parimi N, et al
    CIRCULATING VITAMIN D, SUPPLEMENT USE, AND CARDIOVASCULAR DISEASE RISK: THE MROS SLEEP STUDY.
    J Clin Endocrinol Metab. 2014 Mar 26:jc20134178.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Osteoporosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: